Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

NCT04830579 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Etoricoxib film-coated tablet 120 mg
DRUG: Arcoxia® film-coated tablet 120 mg

Sponsor

Pharmtechnology LLC

Collaborators

[object Object]